Wick Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Wick Capital Partners's LLY Position: Q3 2026 in Review
Wick Capital Partners reduced its Eli Lilly (LLY) stake by 8.1% in Q3 2026, selling an estimated $85K and leaving 819 shares worth $948K. The position accounts for 0.12% of the portfolio, ranked #79.
Wick Capital Partners first reported a position in LLY in Q2 2024 and has held it in 10 quarters since. The position peaked at $1.07M in Q2 2026. 4,599 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Wick Capital Partners held 819 shares of Eli Lilly worth $948K as of Q3 2026.
- Wick Capital Partners sold 72 Eli Lilly shares in Q3 2026, an estimated $85K.
- Eli Lilly made up 0.12% of Wick Capital Partners's portfolio in Q3 2026, its #79 holding.
- Wick Capital Partners first reported a position in Eli Lilly in Q2 2024 and has held it in 10 quarters since.
- Wick Capital Partners's Eli Lilly position peaked at $1.07M in Q2 2026.
- 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Wick Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.